UBS O'Connor’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,000
| Closed | -$510K | – | 613 |
|
|
2023
Q2 | $510K | Sell |
5,000
-250
| -5% | -$25.5K | 0.01% | 433 |
|
|
2023
Q1 | $477K | Buy |
+5,250
| New | +$477K | 0.01% | 455 |
|
|
2019
Q1 | – | Sell |
-17,178
| Closed | -$964K | – | 157 |
|
|
2018
Q4 | $964K | Buy |
17,178
+4,874
| +40% | +$274K | 0.03% | 158 |
|
|
2018
Q3 | $1.01M | Buy |
+12,304
| New | +$1.01M | 0.02% | 201 |
|
|
2017
Q4 | – | Sell |
-83,364
| Closed | -$2.59M | – | 372 |
|
|
2017
Q3 | $2.59M | Buy |
+83,364
| New | +$2.59M | 0.04% | 244 |
|